Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingbei Zhike Granules for Postinfectious Cough (Wind-Heat Attacking Lung Pattern)
CTR20243150Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xingbei Zhike Granules in postinfectious cough, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Aug 2024; status: completed.
02
Drugs
Xingbei Zhike Granules
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on CTR20243150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243150.